Published in Cancer Weekly, November 1st, 2005
If ovarian cancer is detected early there is a very good prognosis for full recovery. Currently, there is no test for early detection of ovarian cancer. PXL has patented several protein and carbohydrate candidate markers for the development of an ovarian cancer diagnostic test.
Melbourne-based PHIMR has previously developed a test to detect ovarian cancer in post-menopausal woman, a significant sector of the target...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.